Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Conditions
Interventions
Naldemedine
Placebo
Locations
65
United States
Shionogi Research Site
Birmingham, Alabama, United States
Shionogi Research Site
Phoenix, Arizona, United States
Shionogi Research Site
Fresno, California, United States
Shionogi Research Site
Long Beach, California, United States
Shionogi Research Site
National City, California, United States
Shionogi Research Site
North Hollywood, California, United States
Start Date
August 29, 2013
Primary Completion Date
January 22, 2015
Completion Date
January 22, 2015
Last Updated
May 30, 2017
NCT06897917
NCT01333540
NCT01901328
NCT01100151
Lead Sponsor
Shionogi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions